Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease.
Toft M, Mata IF, Ross OA, Kachergus J, Hulihan MM, Haugarvoll K, Stone JT, Blazquez M, Gibson JM, Aasly JO, White LR, Lynch T, Adler CH, Gwinn-Hardy K, Farrer MJ.
Toft M, et al.
Mov Disord. 2007 Feb 15;22(3):389-92. doi: 10.1002/mds.21217.
Mov Disord. 2007.
PMID: 17216639